Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail

British Journal of Dermatology

Volumn 166, Issue 6, 2012, Pages 1184-1197

  Hao, L ^a   Ha, J R ^a   Kuzel, P ^a   Garcia, E ^a   Persad, S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SERINE; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; WORTMANNIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL JUNCTION; CELL MEMBRANE; CELLULAR DISTRIBUTION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE SWITCHING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MELANOMA; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

CADHERINS; CELL LINE, TUMOR; CELL MEMBRANE; DISEASE PROGRESSION; HUMANS; MELANOMA; PHOSPHATIDYLINOSITOL 3-KINASES; PTEN PHOSPHOHYDROLASE; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA, MESSENGER; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFECTION; TWIST TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84861594264     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10824.x     Document Type: Article

References (40)

1. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A,. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002; 109: 987-91.
2. Bonitsis N, Batistatou A, Karantima S, et al. The role of cadherin/catenin complex in malignant melanoma. Exp Oncol 2006; 28: 187-93.
3. Bryant DM, Stow JL,. The ins and outs of E-cadherin trafficking. Trends Cell Biol 2004; 14: 427-34.
4. d'Souza-Schorey C,. Disassembling adherens junctions: breaking up is hard to do. Trends Cell Biol 2005; 15: 19-26.
5. Krengel S, Groteluschen F, Bartsch S, et al. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. J Cutan Pathol 2004; 31: 1-7.
6. Alonso SR, Tracey L, Ortiz P, et al. A high-throughput study in melanoma identifies epithelial mesenchymal transition as a major determinant of metastasis. Cancer Res 2007; 67: 3450-60.
7. Hirohashi S,. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 333-9.
8. Sansal I, Sellers WR,. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 2004; 22: 2954-63.
9. Guldberg P, thor Straten P, Birck A, et al. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 2007; 57: 3660-3.
10. Tsao H, Zhang X, Benoit E, Haluska FG,. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 1998; 16: 3397-402.
11. Wu H, Goel V, Haluska FG,. PTEN signaling pathways in melanoma. Oncogene 2003; 22: 3113-22.
12. Trotman LC, Niki M, Dotan ZA, et al. PTEN dose dictates cancer progression in the prostate. PLoS Biol 2003; 1: E59.
13. Dhawan P, Singh AB, Ellis DL, Richmond A,. Constitutive activation of Akt/protein kinase B in melanoma leads to upregulation of nuclear factor-kappaB and tumor progression. Cancer Res 2002; 62: 7335-42.
14. Wang H, Quah SY, Dong JM, et al. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res 2007; 67: 2922-6.
15. Bowen KA, Doan HQ, Zhou BP, et al. PTEN loss induces epithelial- mesenchymal transition in human colon cancer cells. Anticancer Res 2009; 29: 4439-49.
16. Batlle E, Sancho E, Franci C, et al. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 84-9.
17. Comijn J, Berx G, Vermassen P, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2004; 7: 1267-78.
18. Poser I, Dominguex D, de Herreros AG, et al. Loss of E-cadherin expression in melanoma cells involves up-regulation of transcriptional repressor Snail. J Biol Chem 2001; 276: 24661-6.
19. Nogueira C, Kim K-H, Sung H, et al. Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Oncogene 2010; 29: 6222-32.
20. Kuphal S, Bosserhoff AK,. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in maliganant melanoma. Oncogene 2006; 25: 248-59.
21. Pavelic ZP, Slocum HK, Rustum YM, et al. Colony growth in soft agar of human melanoma, sarcoma, and lung carcinoma cells disaggregated by mechanical and enzymatic methods. Cancer Res 1980; 40: 2160-4.
22. Vivanco I, Sawyers CL,. The phosphatidylinositol 3-kinase-akt pathway in human cancer. Nat Rev Cancer 2002; 2: 489-501.
23. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-39.
24. Cano A, Perez-Moreno M, Rodrigo I, et al. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83.
25. Bolós V, Peinada H, Pérez Moreno MA, et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003; 116: 499-511.
26. Peinado H, Ballestar E, Esteller M, et al. Snail mediates E-cadherin repression by the recruitment of the Sin3a/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004; 24: 306-19.
27. Chiang AC, Massague J,. Molecular basis of metastasis. N Engl J Med 2008; 359: 2814-23.
28. Kailluri R, Weinberg RA,. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-8.
29. Hocker T, Tsao H,. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum Mutat 2007; 28: 578-88.
30. Lin K, Baritaki S, Militello L, et al. The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-κB/Snail/ RKIP/PTEN circuit. Genes Cancer 2010; 1: 409-20.
31. Zhang S, Dihua Y,. PI(3)King apart PTEN's role in cancer. Clin Cancer Res 2010; 16: 4325-30.
32. Weng L, Brown J, Eng C, et al. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Hum Mol Genet 2001; 10: 237-42.
33. Freeman DJ, Li AG, Wei G, et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 2003; 3: 117-30.
34. Vasudevan KM, Barbie DA, Davies MA, et al. Akt-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell 2009; 16: 21-32.
35. Wu X, Hepner K, Castelino-Prabhu S, et al. Evidence for regulation of PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci USA 2000; 97: 4233-8.
36. Subauste MC, Nalbant P, Adamson ED, et al. Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein β-catenin with the scaffolding protein MAGI-2. J Biol Chem 2005; 280: 5676-81.
37. Tolkacheva T, Boddapati M, Sanfiz A, et al. Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383. Cancer Res 2001; 61: 4985-9.
38. Hu Y, Li Z, Guo L, et al. MAGI-2 inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells. Arch Biochem Biophys 2007; 467: 1-9.
39. Gumbiner BM,. Regulation of cadherin adhesive activity. J Cell Biol 2000; 148: 399-404.
40. Ohkubo T, Ozawa M,. The transcription factor snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 2004; 117: 1675-85.